Evidence map›Paper›PMID 42085531›Full record

ArticleScience signaling2026

A

Wang Yuan, Luke A Nunamaker, Yi M Weaver, Benjamin P Weaver

Abstract read
In one paragraph

Article in Science signaling, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Wang YuanDepartment of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.ORCID 0000-0003-1575-4596
Luke A NunamakerDepartment of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.ORCID 0009-0000-2983-6475
Yi M WeaverDepartment of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.ORCID 0000-0002-8993-2001
Benjamin P WeaverDepartment of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.ORCID 0000-0002-0830-213X

Funding

Proteolytic Mechanisms Mediating Diverse Non-Apoptotic Caspase FunctionsR35GM133755 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI Benjamin P. Weaver · 2019 to 2026
$3.7M
Unmasking p38 MAPK Functions in Lysosome Homeostasis during Development and AgingR21AG086710 · NIA · UT SOUTHWESTERN MEDICAL CENTER · PI WEAVER, BENJAMIN P. · 2024 to 2024
$451k
NIA NIH HHS R21 AG086710NIGMS NIH HHS R35 GM133755
6 · The paper itself

Abstract

Phenotypic plasticity, the ability to change diverse traits without altering genomic information, is fundamental for organismal adaptations to changing environments. The mitogen-activated protein kinase (MAPK) pathway plays a key role in cellular adaptations to changing environments. To analyze the contributions of the MAPK p38 and its interaction partners to phenotypic plasticity in an animal, we established an in vivo proximity labeling proteomics method called ContinuumID. With this method, we built an atlas of PMK-1 physical interactors during development, in specific tissues, and during exposure to osmotic, ultraviolet, or oxidative stressors. We identified multiple stable and dynamic developmental stage-, tissue-, and stress-specific PMK-1 interactors. Phenotypic analyses of animals in which specific interactors were knocked down revealed considerable variability of diverse PMK-1-dependent outputs. These included target gene expression, survival under stress, lysosomal homeostasis during development, and neuronal integrity during aging. PMK-1 interactors exerted positive, negative, and neutral contributions to these outputs within and across functional pathways. Comparing developmental and stress-induced activation of PMK-1 and the regulatory functions of its interactors revealed that PMK-1 integrates the regulation of highly conserved protein synthesis and RNA processing pathways with that of rapidly changing signaling and metabolic adaptations to confer distinct survival advantages or disadvantages during stress.

Indexed as

Caenorhabditis elegansCaenorhabditis elegans ProteinsMAP Kinase Signaling Systemp38 Mitogen-Activated Protein KinasesAnimalsOxidative StressPhenotypeProteomicsStress, PhysiologicalCaenorhabditis elegans Proteinsp38 Mitogen-Activated Protein Kinases

Identifiers

PMID42085531
PMCPMC13198063

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.